Related references
Note: Only part of the references are listed.Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients
Wei-Ting Chang et al.
ARCHIVES OF TOXICOLOGY (2021)
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Valentina Rausch et al.
ONCOGENESIS (2021)
Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations
Jeremy R. Stone et al.
JCO ONCOLOGY PRACTICE (2021)
Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations
Jeremy R. Stone et al.
JCO ONCOLOGY PRACTICE (2021)
Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)
Yosuke Takamiya et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2020)
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Gioacchino P. Marceca et al.
FRONTIERS IN ONCOLOGY (2020)
Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking Studies
Shenouda G. Eliaa et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
SGLT2 Inhibitors Play a Salutary Role in Heart Failure via Modulation of the Mitochondrial Function
Yasuhiro Maejima
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
DR-region of Na+/K+-ATPase is a target to ameliorate hepatic insulin resistance in obese diabetic mice
Hai-Jian Sun et al.
THERANOSTICS (2020)
Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy
Basant Sharma et al.
CARDIOVASCULAR TOXICOLOGY (2019)
Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension
Keith C. Ferdinand et al.
CIRCULATION (2019)
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Neel I. Nissen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Biomarkers in acute myocardial infarction: current perspectives
Suleyman Aydin et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2019)
Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors
Samir Rabadiya et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure
John J. V. McMurray et al.
JACC-HEART FAILURE (2018)
Cardiac complications in cancer treatment - A review
Xianchi Li et al.
HELLENIC JOURNAL OF CARDIOLOGY (2017)
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
TNF-α and cancer cachexia: Molecular insights and clinical implications
Hetal J. Patel et al.
LIFE SCIENCES (2017)
Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review)
Yassine Belloum et al.
ONCOLOGY REPORTS (2017)
A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction
Nienke A. Hesen et al.
PLOS ONE (2017)
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)
Matthew A. Cavender et al.
CIRCULATION (2017)
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes
Takehiro Hashikata et al.
HEART AND VESSELS (2016)
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
Kate T. Murphy
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice
Qixue Wang et al.
SCIENTIFIC REPORTS (2016)
Cardiovascular safety of anti-diabetic drugs
R. Kumar et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
Losartan treatment attenuates tumor-induced myocardial dysfunction
Sarah C. W. Stevens et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus
Aris Liakos et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2015)
Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction
Nihar Rayabarapu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2014)
Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction
Chris P. H. Lexis et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril
Bhoomika M. Patel et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2014)
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure
Jochen Springer et al.
EUROPEAN HEART JOURNAL (2014)
Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice
Hironobu Tsubouchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus
Bhoomika M. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy
Bhoomika M. Patel et al.
PHARMACOLOGICAL REPORTS (2014)
Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications
Suchi Raghunathan et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Pathological Ventricular Remodeling: Therapies: Part 2 of 2
Min Xie et al.
CIRCULATION (2013)
Effect of Spironolactone on Cardiovascular Complications Associated with Type-2 Diabetes in Rats
B. M. Patel et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy
Bhoomika R. Goyal et al.
ACTA CARDIOLOGICA (2012)
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy
Jenny P. Nobes et al.
BJU INTERNATIONAL (2012)
Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations
B. M. Patel et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Obesity suppresses circulating level and function of endothelial progenitor cells and heart function
Tzu-Hsien Tsai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
NF-κB Inhibition Protects against Tumor-Induced Cardiac Atrophy in Vivo
Ashley Wysong et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidney
Jianfeng Li et al.
CANCER BIOLOGY & THERAPY (2011)
Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice
Min Tian et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Myocardial dysfunction in an animal model of cancer cachexia
Hui Xu et al.
LIFE SCIENCES (2011)
Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia
Patricia W. Seo-Mayer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Blood sample collection in small laboratory animals
S. Parasuraman et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2010)
Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
Bhoomika R. Goyal et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats
Bhoomika R. Goyal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Burn injury decreases myocardial Na-K-ATPase activity: Role of PKC inhibition
Jureta W. Horton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects
S. Iannello et al.
OBESITY REVIEWS (2007)
Oxidative stress causes heart failure with impaired mitochondrial respiration
Hidetoshi Nojiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Myocardial PKC β2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension
OV Fedorova et al.
HYPERTENSION (2003)
Creatine kinase-MB elevation after stroke is not cardiac in origin - Comparison with troponin T levels
H Ay et al.
STROKE (2002)
Share Paper
